GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin

Martin Stieger, Peter Angehrn, Beatrice Wohlgensinger, Hans Gmünder

Antimicrobial Agents and Chemotherapy · 1996 · 57 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

The sequence of the gyrase B subunit gene from Staphylococcus aureus strains resistant to the gyrase B subunit inhibitors cyclothialidine, coumermycin, and novobiocin has been determined. The residues altered in the resistant gyrase B subunits map to the ATP-binding region, suggesting that the drugs inhibit ATP binding and hydrolysis. The pattern of cross-resistances indicates that the detailed binding mode of the compounds differs.

References

30